Wenlong Yu

1.7k total citations
50 papers, 1.2k citations indexed

About

Wenlong Yu is a scholar working on Surgery, Oncology and Cancer Research. According to data from OpenAlex, Wenlong Yu has authored 50 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 20 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Wenlong Yu's work include Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers), MicroRNA in disease regulation (9 papers) and Cancer-related molecular mechanisms research (9 papers). Wenlong Yu is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers), MicroRNA in disease regulation (9 papers) and Cancer-related molecular mechanisms research (9 papers). Wenlong Yu collaborates with scholars based in China, United States and Hong Kong. Wenlong Yu's co-authors include Ningjia Shen, Yongjie Zhang, Guanzhen Yu, Xiaohui Fu, Wen‐Ming Cong, Yongjie Zhang, Guang‐Zhi Jin, Mengchao Wu, Bin Yi and Hui Dong and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Annals of Surgery.

In The Last Decade

Wenlong Yu

47 papers receiving 1.2k citations

Peers

Wenlong Yu

SURGE

ONCOL

PRM

Yunfeng Shan China

Lawrence A. Shirley United States

Annalisa Altimari Italy

Yoshikuni Inokawa Japan

Lechi Ye China

Limei Guo China

Hong Yu China

Mingheng Liao China

Jieqiong Liu China

Anna Fen‐Yau Li Taiwan

Yunfeng Shan China

Wenlong Yu

627 ×1.3

403 ×0.9

233 ×0.6

SURGE

311 ×1.0

ONCOL

209 ×0.7

PRM

Citations per year, relative to Wenlong Yu Wenlong Yu (= 1×) peers Yunfeng Shan

Countries citing papers authored by Wenlong Yu

Since Specialization

Citations

This map shows the geographic impact of Wenlong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenlong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenlong Yu more than expected).

Fields of papers citing papers by Wenlong Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenlong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenlong Yu. The network helps show where Wenlong Yu may publish in the future.

Co-authorship network of co-authors of Wenlong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenlong Yu. A scholar is included among the top collaborators of Wenlong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenlong Yu. Wenlong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sedighi, Abootaleb, et al.. (2025). Monoselective Histone Deacetylase 6 PROTAC Degrader Shows In Vivo Tractability. Journal of Medicinal Chemistry. 68(6). 6165–6177. 5 indexed citations

Sun, Yan, et al.. (2025). Association of intra-individual differences in estimated GFR by creatinine versus cystatin C with incident cardiovascular disease. Nutrition Metabolism and Cardiovascular Diseases. 35(9). 104034–104034.

Liu, Chunliang, Xiang Wang, Erdong Liu, et al.. (2025). Deciphering cholangiocarcinoma heterogeneity and specific progenitor cell niche of extrahepatic cholangiocarcinoma at single-cell resolution. Journal of Hematology & Oncology. 18(1). 66–66. 1 indexed citations

Deng, Haishan, et al.. (2024). Metformin Increases the Response of Cholangiocarcinoma Cells to Gemcitabine by Suppressing Pyruvate Kinase M2 to Activate Mitochondrial Apoptosis. Digestive Diseases and Sciences. 69(2). 476–490.

Yu, Wenlong, et al.. (2024). Efficacy and safety of BaitouWeng decoction for ulcerative colitis: A meta-analysis of randomized and controlled trials. Medicine. 103(27). e38704–e38704. 3 indexed citations

Zhang, Bo, et al.. (2024). Generating more constrained seeds for seismic horizon extraction. Geophysics. 89(6). IM77–IM90.

Dai, Chun, et al.. (2024). HBcrAg is associated with prognosis of hepatitis B virus‐related hepatocellular carcinoma in patients after hepatectomy undergoing antiviral therapy. International Journal of Cancer. 156(6). 1293–1303. 1 indexed citations

Wu, Qing, Xinyi Liao, Jiahua Xu, et al.. (2022). The Chemopreventive Role of β-Elemene in Cholangiocarcinoma by Restoring PCDH9 Expression. Frontiers in Oncology. 12. 874457–874457. 9 indexed citations

Shen, Ningjia, Yan Shi, Xiaohui Fu, et al.. (2022). Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data. Frontiers in Immunology. 13. 1009789–1009789. 79 indexed citations

10.

Wang, Xiang, Chunliang Liu, Jianan Chen, et al.. (2022). Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma. Cell Discovery. 8(1). 101–101. 39 indexed citations

11.

Yuan, Bo, et al.. (2019). Does Anatomic Resection Get More Benefits than Wedge Hepatectomy on the Prognosis for pT3 Unsuspected Gallbladder Cancer?. Journal of Laparoendoscopic & Advanced Surgical Techniques. 29(11). 1414–1418. 7 indexed citations

12.

Wang, Xiang, Wenlong Yu, Xiaohui Fu, et al.. (2019). Early Versus Delayed Surgical Repair and Referral for Patients With Bile Duct Injury. Annals of Surgery. 271(3). 449–459. 35 indexed citations

13.

Jiao, Xiao‐Dong, Wenlong Yu, Jianxin Qian, et al.. (2018). ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1. BMC Cancer. 18(1). 570–570. 15 indexed citations

14.

Li, Chuansheng, Jingwei Zhang, Zhongliang Ma, Fan Zhang, & Wenlong Yu. (2018). miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway. OncoTargets and Therapy. Volume 11. 4087–4095. 36 indexed citations

15.

Zhou, Di, Jiandong Wang, Yong Yang, et al.. (2016). Individualized nomogram improves diagnostic accuracy of stage I-II gallbladder cancer in chronic cholecystitis patients with gallbladder wall thickening. Hepatobiliary & pancreatic diseases international. 15(2). 180–188. 11 indexed citations

16.

Kong, Qing, Haojie Lu, Zhongxin Lu, et al.. (2014). Pectolinarigenin - A Flavonoid Compound from <i>Cirsium Japonicum</i> with Potential Anti-proliferation Activity in MCF- 7 Breast Cancer Cell. Tropical Journal of Pharmaceutical Research. 13(2). 225–225. 21 indexed citations

17.

Yu, Wenlong, et al.. (2014). Effect Evaluation of Vascular Resection for Patients with Hilar Cholangiocarcinoma: Original Data and Meta-analysis. Cell Biochemistry and Biophysics. 69(3). 509–516. 18 indexed citations

18.

Luo, Xiangji, Tong Kan, Yongjie Zhang, et al.. (2013). TGF-β upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1. Molecular BioSystems. 10(3). 679–685. 47 indexed citations

19.

Yang, Liqun, et al.. (2010). A clinical prospective comparison of anesthetics sensitivity and hemodynamic effect among patients with or without obstructive jaundice. Acta Anaesthesiologica Scandinavica. 54(7). 871–877. 23 indexed citations

20.

Song, Jin‐Chao, et al.. (2010). A Comparison of Liver Function After Hepatectomy with Inflow Occlusion Between Sevoflurane and Propofol Anesthesia. Anesthesia & Analgesia. 111(4). 1036–1041. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact